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The pathogenesis of multiple myeloma (MM), an incurable 
tumour causing the deregulated proliferation of terminally 
differentiated 8 cells, is unknown 1• Chromosomal 
translocations (14q1) affecting band 14q32 and unidentified 
partner chromosomes are common in this tumour, suggesting 
that they may cause the activation of novel oncogenes2.3. By 
cloning the chromosomal breakpoints in an MM cell line, we 
show that the 14q+ translocation represents a t(6;14)(p2S;q32) 
and that this aberration is recurrent in MM, as it was found in 
two of eleven MM cell lines. The translocation juxtaposes the 
immunoglobulin heavy-chain (lgH) locus to MUM1 (mM:Itiple 
myeloma oncogene 1JIIRF4 gene, a member of the interferon 
regulatory factor (IRF) family known to be active in the control 
of 8-cell proliferation and differentiation. As a result, the 
MUM1RRF4 gene is overexpressed-an event that may 
contribute to tumorigenesis, as MUM11/RF4 has oncogenic 
activity in vitro. These findings identify a novel genetic 
alteration associated with MM, with implications for the 
pathogenesis and diagnostics of this tumour. 
Chromosomal aberrations in the IgH locus on band 14q32 
( 14q+) are common in multiple myeloma (MM) ( 62% of cases) 
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and represent translocations of a variety ofloci 
into the IgH switch region4•5• With the excep-
tion of some cases involving the BCL-1 locus on 
chromosome llql3 (ref. 6), the genes implicat-
ed in the partner chromosomes have not been 
identified. To investigate the nature of the 
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sequences linked to the IgH locus in 14q+ chro-
mosomes, we screened a number of cell lines for 
the presence of abnormally re-arranged IgHloci 
that could reflect the presence of chromosomal 
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translocations. We used a Southern-blot 
hybridization assay aimed at identifying re-
arranged IgH alleles in which IgH joining (JH) 
and constant (C) region (CJ.t, Cy or S'{, Ca) 
sequences are not linked, as these alleles reflect 
illegitimate IgH switch recombinations that often 
represent chromosomal translocations7• When 
we used this assay, nine of eleven MM lines test-
ed showed evidence of illegitimate switch recom-
binations (not shown)-a result consistent with 
a recent report using a similar assayS. 
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The pattern of IgH gene re-arrangements 
detectable in the SK-MM-1 cell line strongly 
suggested the presence of a chromosomal 
translocation (Fig. la). BamHI digestion ofSK-
MM -1 genomic DNA and hybridization with a 
JH probe showed a restriction fragment 
(12.0 kb) that did not hybridize with any C 
Fig. 1 Molecular cloning of 14q+ chromosome breakpoints in SK-MM-1 cells. a, Southern-blot 
analysis showing aberrant re-arrangements of the lgH locus. Arrowheads show rearranged non-
reciprocally linked JH and C~J. fragments. Co-migrating fragments (JH-Cy2, left; C~J.-0. 78/H, right) 
are linked by dashed lines. b, Schematic representation of the A.SK8-4a and A.SKS-3 clones, repre-
senting der(6) and der(14) breakpoints, and of the germ line lgH and MUM11oci. The MUM1 
germline locus shows the genomic organization of the MUM1 gene. Filled and empty boxes indi-
cate coding and non-coding exons, respectively. The position and size of each exon, as well as their 
number, are approximate and have been determined by the pattern of hybridization of various 
eDNA probes, as well as by the presence of shared restriction sites in the genomic and eDNA 
sequences. Translation initiation (ATG) and stop (TGA) codons are indicated. Genomic probes used 
for Southern analysis are shown as solid bars below the map. Arrows indicate the position of the 
chromosomal breakpoint in the SK-MM-1 cell line. 8, BamHI; E, EcoRI; H, Hindlll. 
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Fig. 2 FISH analysis of metaphase spreads derived from normal lymphocytes (a) and XG-7 cells (b). a, The MUM! locus mapped to chromosome 6p25 by FISH 
analysis using a 360-kb non-chimaeric YAC (y927E3). b, Splitting of YAC y927E3 signal to chromosome 6p25 and 14q32 in a metaphase spread from XG-7 cells. This 
cell line displays monosomy of chromosome 14. The right panel of each FISH picture displays the corresponding DAPI image, showing a G-banding-like stain. 
probes, while a CfJ. probe identified a 6.5-kb fragment that did not 
contain any J sequences. The 12.0-kb and 6.5-kb fragments were 
considered potential chromosomal breakpoints and cloned from 
a phage library constructed from SK-MM -1 genomic DNA (clones 
A.SKB-4a; A.SKS-3 in Fig. lb). A 0.7B/H probe from the A.SKS-3 
phage insert representing non-IgH sequences (Fig. lb) was used 
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to clone the corresponding normal locus from a library con-
structed from normal human DNA (Fig. 1 b). This locus was 
assigned the name MUMI ( multiple myeloma oncogene 1; 
HUGO/GDB Nomenclature Committee). Restriction enzyme 
analysis (Fig. 1 b) and partial nucleotide sequencing (not shown) 
suggested that the two SK-MM-1 phage inserts contain the chro-
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Fig. 3 MUM11/RF4 expression. a, Northern-blot analysis of 
MUM11/RF4 RNA expression in various lymphoid and non-lym-
phoid cell lines (left) and in B-cell lines derived from various 
stages of differentiation (right) . HELA, epithelial lineage; LCL, 
Epstein-Barr virus-transformed B lymphoblastoid cell line; HUT-
78 and MOLT-4, T-cell lineage; HL-60 and U937, myelomonocyt-
ic lineage; K562, erythroid lineage; 697, pre-B-cell stage; 
RAMOS and BlA-B, Burkitt lymphoma -derived cell lines repre-
senting mature B-cell stage; RPMI-8226 and U-266, multiple-
myeloma cell lines. Dashes indicate 285 and 185 ribosomal RNA 
markers. b, Northern-blot analysis of MUM11/RF4 RNA expres-
sion in MM cell lines. The right panel provides a densitometric 
quantitation of MUM! mRNA levels after normalization 
against ~ACTIN RNA levels. Filled and open dots indicate the 
MUM71/RF4 levels in MM cell lines carrying normal locus and 
translocated (SK-MM-1, XG-7) MUM! locus, respectively. IL-6{-), 
IL-6-independent MM cell lines; IL-6{+), IL-6-dependent MM 
cell lines; although XG-7 cells are described as IL-6 dependent 
and grow with better viability in the presence of rlL-6. these 
cells are capable of proliferation in the absence of ll-6; 
c, Western-blot analysis of MUM 1/1RF4 protein expression in 
MM cell lines. The 50-kD MUM1 protein is shown by the arrow-
head. p-actin levels were shown below to control for the 
amounts of the loaded protein. The SK-MM-1 and the XG-7 
cell lines show 9.0- and 3.5-fold MUM 1/1RF4 overexpression 
compared to two other MM cell lines, respectively. 
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chromosomal breakpoints contained a transcriptional unit by 
northern-blot analysis of RNAs from various cell lines using mul-
tiple probes spanning the MUMJ1ocus .. Probe 2.1H (Fig. lb) 
detected a major 6-kb RNA in B-celllines representative of various 
stages ofB-cell differentiation (from pre-B cells through to plas-
ma cells), as well as in lines displaying a mature T-cell phenotype 
(Fig. 3a). This result indicates that 6p25 sequences immediately 
adjacent to the chromosomal breakpoints are part of a gene 
(MUMJ) that is transcribed in lymphoid tissues. 
The full-length MUMJ eDNA was cloned from a eDNA library 
derived from normal human spleen and sequenced. This analysis 
showed that the predicted MUMJ protein product was virtually 
identical to the IRF4 gene (also called ICSAT, PIP 
or LSIRF), a member of the IRF family of tran-
scription factors8- 11 . This family includes at least 
six molecules that share homologous N-terminal 
DNA-binding domains and are active in the regu-
lation of gene expression in response to signalling 
by interferons and by other cytokines12-1S_ 
To determine the consequences of the translo-
cation on the structure of the MUMJ/IRF4 gene, 
we used the MUMJ/IRF4 eDNA to determine the 
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• 2. 500/dlah exon-intron organization of the corresponding 
genomic locus (Fig. 1 b). This allowed us to deter-
mine that the chromosomal breakpoint was locat-
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ed 3' to the MUMJ/IRF4 gene in SK-MM-1 cells 
(Fig. 1 b), indicating that the t(6;14) translocation 
had juxtaposed the switch region of IgH locus 3' 
to the MUMJ/IRF4 gene in the same transcrip-
tional orientation. The entire MUMJ/IRF4 tran-
scriptional unit appeared intact, suggesting that its 
coding potential is normal, though its regulation 
Fig. 4 MUM1/IRF4 overexpression can transform Rat-1 fibroblasts in vitro. a, Western-blot 
analysis of MUM7//RF4-transfected (CMV-MUM1-HA) and control-transfected (CMV) Rat-1 cell 
clones (cl) using the anti-HA (12CA5) MoAb. The 52-kD MUM1-HA protein is shown by an 
arrowhead. b, Anchorage-independent growth of Rat-1 cells expressing the exogenous MUM1-
HA protein. The graph shows the number of colonies formed by each clone at three seeding 
densities (indicated at the right). Error bars indicate +150. 
may be affected by IgH regulatory elements, par-
ticularly the late B-cell-specific transcriptional 
enhancer located 3' to Ca locus16• Probes span-
ning 55 kb of the MUM11ocus, including the 
MUMJ/IRF4 gene and 5' and 3' flanking sequen-
ces, failed to detect rearrangements in ten MM cell 
mosomal breakpoints of a reciprocal balanced translocation in 
the IgH and the MUMJ loci. 
To determine the chromosomal origin of MUMJ sequences, a 
360-kb non-chimaeric yeast artificial chromosome (YAC) com-
mittee (y927E3) spanning the MUMJ breakpoint region was used 
as a probe in fluorescence in situ hybridization (FISH) analysis of 
metaphase spreads from normal human lymphocytes. This analy-
sis indicated that MUMI is located on chromosome 6p25 (Fig. 2a); 
Southern-blot hybridization of the 2.1H and 4.5A probes (Fig. 1 b) 
to DNA from somatic-cell hybrids representative of individual 
human chromosomes confirmed the mapping to chromosome 6 
(not shown). The same YAC probe was then used to analyse the 
MUM11ocus in eleven MM cell lines, including SK-MM-1. In SK-
MM-1 cells (not shown), as well as in a second MM cell line (XG-7), 
the YAC hybridized to the 14q+ chromosome [ der( 14)] as well as to 
a der(6) chromosome (in addition to normal chromosomes 6) 
(Fig. 2b), whereas no abnormality was detectable in nine addition-
al MM lines. Thus, the 14q+ chromosome was part of a reciprocal 
t(6;14)(p25;q32) in the SK-MM-1, while the FISH results strongly 
suggest the presence of an analogous aberration in XG-7 cells. These 
translocations were undetectable by conventional cytogenetic analy-
sis because of the relatively small size of the telomeric region translo-
cating from chromosome 6. This translocation is recurrent in MM, 
as it was detectable in two of eleven cases tested. 
Next we investigated whether the MUMllocus adjacent to the 
228 
lines and eighteen MM cases studied (not shown). 
These cell lines included the XG-7 line, which was 
shown to contain a t(6;14)(p25;q32) by FISH analysis (Fig. 2b), 
suggesting that, analogous to other translocations in Iggenes6•17, 
the breakpoints oft(6;14)(p25;q32) can scatter along 6p25 at vari-
able distances from the MUMllocus. 
To investigate the functional consequences of chromosomal 
translocation on MUMJ/IRF4 expression, we compared the lev-
els of MUMJ/IRF4 RNA in MM cell lines carrying 
t(6;14)(p25;q32) (SK-MM-1, XG-7) or lacking detectable 6p25 
abnormalities. In general, the levels of MUMJ/IRF4 RNA expres-
sion tended to be higher (3.4-fold) in interleukin-6 (IL-6)-depen-
dent than in IL-6-independent MM cell lines (Fig. 3b). However, 
SK-MM -1 and the XG-7 cell lines displayed the highest levels of 
MUMJ/IRF4 expression, a 7.5- and a 6-fold overexpression com-
pared to the average of other MM cell lines (Fig. 3b). Immunoblot 
analysis ofSK-MM-1 and XG-7 cell lines showed that increased 
RNA expression was associated with increased levels of 
MUMJ/IRF4 protein expression (Fig. 3c). Electrophoretic mobil-
ity shift assay (EMSA) of nuclear extracts using an IRF binding 
site as a probe (GBP-ISRE) 10 showed that both cell lines carrying 
alterations of the MUMllocus (SK-MM-1 and XG-7) had higher 
amounts of DNA-bound MUM1/IRF4 than control MM lines (not 
shown) . Collectively, these results indicated that the functional 
consequence of chromosomal translocation is the deregulation of 
MUM1/IRF4 gene expression, leading to the production of 
increased amounts of functional MUM 1/IRF4 protein. 
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To investigate whether MUM1/IRF4 deregulation could contribute 
to malignant transformation, we tested whether transfection of a 
MUMJIIRF4 expression vector in Rat-1 fibroblasts could increase 
their donogenic properties in agar, a typical sign of malignant trans-
formation. We transfected Rat-1 cells with an expression vector 
(CMV-MUMl-HA) in which a CMV promoter drives the expres-
sion of MUM1/IRF4 tagged by a haemagglutinin (HA) epitope rec-
ognizable from a specific monoclonal antibody. CMV-MUM1-HA 
transfected Rat -1 clones expressing detectable levels of exogenous 
MUMl-HA protein (Fig. 4a), but not control (CMV) transfected 
clones, acquired anchorage-independent growth in soft agar (Fig. 4b). 
These clones also displayed higher saturation density than trans-
fected control clones during growth in vitro [ ( 1.52 ± 0.31) ( 106 cm-2 
versus (0.80 ± 0.35) (106 cm-2] (not shown). These results indicate 
that MUM1/IRF4 can behave as an oncogene in vitro and support 
the notion that it may contribute to oncogenesis in vivo. 
Several studies have shown that gene alterations commonly asso-
ciated with most human tumours, such as inactivation of the p53 
tumour-suppressor gene and RAS oncogene mutations, can be 
found in MM18•19. However, these lesions are found at low fre-
quency and in association with advanced stages of the disease, sug-
gesting that their role may be limited to tumour progression. 
Although in the present study the evidence of involvement of the 
MUMJ1ocus is limited to MM cell lines, these alterations are asso-
ciated with l4q+, a cytogenetic aberration often detectable at diag-
nosis20. This suggests that MUM1/IRF4 deregulation may be 
associated with early stages of MM development. 
A role of MUM1/IRF4 deregulation in oncogenesis is support-
ed by its oncogenic activity in vitro (Fig. 4) and is consistent with 
the role of other IRFs as oncogenes and tumour-suppressor genes 
in various experimental systems21-24. MUM1/IRF4 has been shown 
to control the differentiation of B cells into plasma cells, as well as 
their proliferation in response to various mitogenic signals25, sug-
gesting that its deregulated expression may directly contribute to 
the aberrant phenotype ofMM cells1• Because its expression does 
not appear to be regulated by IFN8•10, MUMl/ IRF4 may act as an 
effector of other cytokines that regulate B-cell development. 
Methods 
Cell lines. The phenotypic features of the MM cell lines used in this study 
(SK-MM-1, RPMI-8226, U-266, EJM, XG-1, XG-2, XG-4, XG-5, XG-6, XG-
7 and XG-10) have been previously reported27- 29. The RPMI-8226 cell line 
was obtained through American Type Culture Collection. The SK-MM-1 
and U-266 cell lines were gifts from A.N. Houghton (Memorial Sloan-
Kettering Cancer Center, New York, NY) and Dr. K. Nilsson (University of 
Uppsala, Uppsala, Sweden), respectively. The six XG cell lines (established 
in the laboratory of one of the authors, B.K.) were cultured in the presence 
of 1 nglmL recombinant IL-6 as described previously29• 
Southern- and northern-blot analyses. Southern- and northern-blot 
analyses were performed as described previously17• The human IgH JH 
(6.6kb BamHI-Hind!II) and IgHC!l (1.3-kb EcoRI) probes were provided 
by S.J. Korsmeyer. The human IgH Cy2 probe (4.0-kb Hindiii-BamHI) 
was provided by V. Bertness. In Southern-blot analysis, high-molecular-
weight DNA (10 !lg) from SK-MM-1 cells or normal human placenta was 
completely digested with BamHI, loaded on each lane and blotted to a 
nitrocellulose filter. The same filter was sequentially hybridized with the 
JH, C!l, Cy2 and 0.7B/H (Fig. 1b) probes. Total RNA (10 !lg) was loaded 
on each lane for northern-blot analysis. 
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Genomic and eDNA library screening and DNA sequence analysis. 
Genomic libraries from SK-MM-1 and human placental DNAs were con-
structed and screened as described previously17• MUMJ eDNA clones 
were isolated from an oligo-dT/random-primed eDNA library construct-
ed from normal human spleen RNA (Clontech). DNA sequences were per-
formed with a ABI 473A DNA sequencer (Applied Biosystems). Sequence 
homology searches were carried out through the BLAST e-mail server at 
the National Center for Biotechnology Information, National Library of 
Medicine, Bethesda, MD. 
YAC isolation and FISH analysis. PCR primers (sense 5'-TACTCGCAC-
CTCTTGGCT-3'; antisense 5'-CTGGAGAGCAATGAACGG-3') derived 
from the 6p25 sequence within the last exon of the MUMJ gene were used 
to screen a human CEPH YAC DNA pool (Research Genetics). Preparation 
of metaphase spreads, YAC DNA extraction and FISH analysis were per-
formed as reported previouslyi7• 
Western-blot analysis. Cell pellets prepared from MM and Rat -1 cells were 
re-suspended in 1 xLaemmli sample buffer and boiled for 5 min. Protein 
lysates derived from 106 cells were fractionated on an SDS (7.5% for MM 
cells or 12.5% for Rat-1 cells) acrylamide gel and transferred to a nitrocel-
lulose membrane (Schleicher & Schuell). The filtre was blocked with 5% 
milk in Iris-buffered saline (TBS)-0.2% Tween and then incubated 
overnight at 4 °C with a 1/400 dilution of anti-ICSAT goat serum (M-17; 
Santa Cruz Biotechnology) or a 1/500 dilution of anti-HA monoclonal 
antibody (MoAb: 12CA5; Boehringer Mannheim) in TBS-0.1 o/o Tween, 
3% bovine serum albumin. This was followed by an incubation with anti-
goat or anti-mouse IgG (l/3,000), horseradish peroxidase-linked antibody 
(Amersham) in TBS-0.1 o/o Tween, 5% milk. Reactive bands were detected 
with an ECL system (Amersham). 
Expression constructs. The MUMl eDNA, comprising a full-length ORF 
plus 96 and 0 bp of 5' and 3' untranslated regions, respectively, was linked 
in-frame to the COOH-terminal HA (MAYPYDVPDYASLGPGP) tag by 
PCR, blunt-ended by Klenow enzyme and cloned into blunt-ended Noti 
site of pHeBo-CMV eukaryotic expression vector30. 
Rat-1 cell transfection and soft-agar assay. Rat-1 cells plated at l x 106 per 
100-mm dish in Dulbecco modified Eagle's medium (DMEM), supple-
mented with !Oo/o fetal bovine serum (FBS), were transfected with 3 pmol 
of pHeBo-CMV or pHeBo-CMV-MUMJ-HA by a modified calcium 
phosphate method30• Forty-eight hours after transfection, cells were 
reseeded into five 100-mm dishes and cultured in DMEM, supplemented 
with 10% FBS containing 600 !lg/ml ofG418. G418-resistant colonies were 
isolated after 10 days of selection. For clonogenicity analysis, Rat -1 cells 
were plated in triplicate at 2.5 x 103, 5 x l 03 and 1 x 104 cells per dish onto 
35-mm agar plates containing DMEM, 10% FBS and 0.5% agar. After 
incubation for 2 weeks at 37 °C, 5% C02, colonies were scored when larg-
er than 0.25 mm. 
GenBank accession numbers. MUMJcDNA, U63738; MUMl 5' genomic 
region, U63739. 
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